1.
Polistena B, Spandonaro F, Capra R, Fantaccini S, Santoni L, Zimatore G, Gasperini C. The societal impact of treatment with natalizumab of relapsing–remitting multiple sclerosis in Italian clinical practice: The Tysabri® PharmacoEconomics (TyPE) Study. GRHTA [Internet]. 12Jun.2019 [cited 2Apr.2020];6(1). Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/463